Best practices for the use of intracerebroventricular drug delivery devices-Reference-Cited by-同舟云学术

Best practices for the use of intracerebroventricular drug delivery devices

Published:2018-07 Issue:3 Volume:124 Page:184-188
ISSN:1096-7192
Container-title:Molecular Genetics and Metabolism
language:en
Short-container-title:Molecular Genetics and Metabolism

Author:

Slavc Irene,Cohen-Pfeffer Jessica L.,Gururangan Sridharan,Krauser Jeanne,Lim Daniel A.,Maldaun Marcos,Schwering Christoph,Shaywitz Adam J.,Westphal Manfred

Funder

BioMarin Pharmaceutical Inc

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference44 articles.

1. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases;Gabathuler;Neurobiol. Dis.,2010

2. Ommaya reservoir infections: a 16-year retrospective analysis;Mead;J. Inf. Secur.,2014

3. Safety of Ommaya reservoirs in children with brain tumors: a 20-year experience with 5472 intraventricular drug administrations in 98 patients;Peyrl;J. Neuro-Oncol.,2014

4. Intrathecal chemotherapy with antineoplastic agents in children;Ruggiero;Paediatr. Drugs,2001

5. Agile delivery of protein therapeutics to CNS;Yi;J. Control. Release,2014

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic efficacy of intracerebral hematopoietic stem cell gene therapy in an Alzheimer’s disease mouse model;Nature Communications;2024-09-13

2. Application and Safety of Externally Controlled Metronomic Drug Delivery to the Brain by an Implantable Smart Pump in a Sheep Model;Neurosurgery;2024-09-06

3. An Overview on the Physiopathology of the Blood–Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery;Pharmaceutics;2024-06-22

4. Systemic administration of a novel Beclin 1-derived peptide significantly upregulates autophagy in the spinal motor neurons of autophagy reporter mice;International Journal of Pharmaceutics;2024-06

5. Targeted Glioma Therapy—Clinical Trials and Future Directions;Pharmaceutics;2024-01-11